| Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies EA Belongia, MD Simpson, JP King, ME Sundaram, NS Kelley, ... The Lancet Infectious Diseases 16 (8), 942-951, 2016 | 697 | 2016 |
| Risk of anaphylaxis after vaccination in children and adults MM McNeil, ES Weintraub, J Duffy, L Sukumaran, SJ Jacobsen, NP Klein, ... Journal of Allergy and Clinical Immunology 137 (3), 868-878, 2016 | 472 | 2016 |
| Risk of unintentional overdose with non-prescription acetaminophen products MS Wolf, J King, K Jacobson, L Di Francesco, SC Bailey, R Mullen, ... Journal of general internal medicine 27, 1587-1593, 2012 | 132 | 2012 |
| Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12 JG Donahue, BA Kieke, JP King, F DeStefano, MA Mascola, SA Irving, ... Vaccine 35 (40), 5314-5322, 2017 | 126 | 2017 |
| Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations L Sukumaran, NL McCarthy, EO Kharbanda, MM McNeil, AL Naleway, ... Jama 314 (15), 1581-1587, 2015 | 126 | 2015 |
| Safety of tetanus, diphtheria, and acellular pertussis and influenza vaccinations in pregnancy L Sukumaran, NL McCarthy, EO Kharbanda, E Weintraub, ... Obstetrics and gynecology 126 (5), 1069, 2015 | 113 | 2015 |
| Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults≥ 60 Years Old EA Belongia, JP King, BA Kieke, J Pluta, A Al-Hilli, JK Meece, V Shinde Open forum infectious diseases 5 (12), ofy316, 2018 | 105 | 2018 |
| Effects of influenza vaccination in the United States during the 2018–2019 influenza season JR Chung, MA Rolfes, B Flannery, P Prasad, A O’Halloran, S Garg, ... Clinical Infectious Diseases 71 (8), e368-e376, 2020 | 96 | 2020 |
| Validation of self‐reported influenza vaccination in the current and prior season JP King, HQ McLean, EA Belongia Influenza and other respiratory viruses 12 (6), 808-813, 2018 | 88 | 2018 |
| Usability of FDA-approved medication guides MS Wolf, J King, EAH Wilson, LM Curtis, SC Bailey, J Duhig, A Russell, ... Journal of general internal medicine 27, 1714-1720, 2012 | 87 | 2012 |
| Developing consumer-centered, nonprescription drug labeling: a study in acetaminophen JP King, TC Davis, SC Bailey, KL Jacobson, LA Hedlund, L Di Francesco, ... American journal of preventive medicine 40 (6), 593-598, 2011 | 85 | 2011 |
| Misunderstanding and potential unintended misuse of acetaminophen among adolescents and young adults LP Shone, JP King, C Doane, KM Wilson, MS Wolf Journal of health communication 16 (sup3), 256-267, 2011 | 83 | 2011 |
| Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012–13, 2013–14, and 2014–15 JG Donahue, BA Kieke, JP King, MA Mascola, TT Shimabukuro, ... Vaccine 37 (44), 6673-6681, 2019 | 56 | 2019 |
| Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US influenza vaccine effectiveness network 2012–2013 JG Petrie, C Cheng, RE Malosh, JJ VanWormer, B Flannery, ... Clinical Infectious Diseases 62 (4), 448-455, 2016 | 55 | 2016 |
| Paid Leave and Access to Telework as Work Attendance Determinants during Acute Respiratory Illness, United States, 2017–2018 F Ahmed, S Kim, MP Nowalk, JP King, JJ VanWormer, M Gaglani, ... Emerging Infectious Diseases 26 (1), 26, 2020 | 52 | 2020 |
| Influenza and workplace productivity loss in working adults JJ Van Wormer, JP King, A Gajewski, HQ McLean, EA Belongia Journal of occupational and environmental medicine 59 (12), 1135-1139, 2017 | 51 | 2017 |
| School absenteeism among school‐aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012‐2013 through 2014‐2015 HQ McLean, SH Peterson, JP King, JK Meece, EA Belongia Influenza and other respiratory viruses 11 (3), 220-229, 2017 | 49 | 2017 |
| Effect of statin use on influenza vaccine effectiveness HQ McLean, BDW Chow, JJ VanWormer, JP King, EA Belongia The Journal of infectious diseases 214 (8), 1150-1158, 2016 | 49 | 2016 |
| Biosafety training and incident-reporting practices in the United States: A 2008 survey of biosafety professionals AT Chamberlain, LAC Burnett, JP King, ES Whitney, SG Kaufman, ... Applied Biosafety 14 (3), 135-143, 2009 | 41 | 2009 |
| Take-Wait-Stop: a patient-centered strategy for writing PRN medication instructions DM McCarthy, TC Davis, JP King, RJ Mullen, SC Bailey, M Serper, ... Journal of health communication 18 (sup1), 40-48, 2013 | 38 | 2013 |
